707 related articles for article (PubMed ID: 20494257)
41. The cost-effectiveness of prenatal carrier screening for cystic fibrosis.
Lieu TA; Watson SE; Washington AE
Obstet Gynecol; 1994 Dec; 84(6):903-12. PubMed ID: 7970468
[TBL] [Abstract][Full Text] [Related]
42. Preconception and prenatal screening for cystic fibrosis.
Baskin LB; Wians FH; Elder F
MLO Med Lab Obs; 2002 Oct; 34(10):8-12; quiz 14, 16. PubMed ID: 12385171
[No Abstract] [Full Text] [Related]
43. CFTR mutation screening in an assisted reproductive clinic.
Field PD; Martin NJ
Aust N Z J Obstet Gynaecol; 2011 Dec; 51(6):536-9. PubMed ID: 21875427
[TBL] [Abstract][Full Text] [Related]
44. Emerging issues in cystic fibrosis newborn screening.
Castellani C; Massie J
Curr Opin Pulm Med; 2010 Nov; 16(6):584-90. PubMed ID: 20814308
[TBL] [Abstract][Full Text] [Related]
45. Association between carrier screening and incidence of cystic fibrosis.
Castellani C; Picci L; Tamanini A; Girardi P; Rizzotti P; Assael BM
JAMA; 2009 Dec; 302(23):2573-9. PubMed ID: 20009057
[TBL] [Abstract][Full Text] [Related]
46. Genetic counselling issues in cystic fibrosis.
Culling B; Ogle R
Paediatr Respir Rev; 2010 Jun; 11(2):75-9. PubMed ID: 20416541
[TBL] [Abstract][Full Text] [Related]
47. Prenatal and newborn screening for CFTR mutations: the difficulties of prediction.
Schwarz MJ
Clin Biochem; 2011 May; 44(7):485-486. PubMed ID: 22036338
[No Abstract] [Full Text] [Related]
48. Parental understanding of newborn screening for cystic fibrosis after a negative sweat-test.
Lang CW; McColley SA; Lester LA; Ross LF
Pediatrics; 2011 Feb; 127(2):276-83. PubMed ID: 21220393
[TBL] [Abstract][Full Text] [Related]
49. Newborn screening programmes including genetic analyses: limits and risks of negative consequences?
Thauvin-Robinet C; Munck A; Roussey M; Huet F; Binquet C; Girodon E
J Epidemiol Community Health; 2010 Nov; 64(11):937-8. PubMed ID: 20558419
[No Abstract] [Full Text] [Related]
50. False negative cystic fibrosis newborn screen.
Collaco JM; Panny SR; Hamosh A; Mogayzel PJ
Clin Pediatr (Phila); 2010 Mar; 49(3):214-6. PubMed ID: 20164071
[No Abstract] [Full Text] [Related]
51. Diagnostic problems in cystic fibrosis - specific characteristics of a group of infants and young children diagnosed positive through neonatal screening, in whom cystic fibrosis had not been diagnosed.
Woś H; Sankiewicz-Szkółka M; Więcek S; Kordys-Darmolińska B; Grzybowska-Chlebowczyk U; Kniażewska M
Dev Period Med; 2015; 19(1):25-31. PubMed ID: 26003067
[TBL] [Abstract][Full Text] [Related]
52. Prenatal diagnosis in a cystic fibrosis family: a combined molecular strategy for a precise diagnosis.
Chávez-Saldaña M; García-Cavazos R; Vigueras RM; Orozco L
Rev Invest Clin; 2011; 63(4):433-5. PubMed ID: 22364044
[TBL] [Abstract][Full Text] [Related]
53. Analysis of 31 CFTR mutations by polymerase chain reaction/oligonucleotide ligation assay in a pilot screening of 4476 newborns for cystic fibrosis.
Gasparini P; Arbustini E; Restagno G; Zelante L; Stanziale P; Gatta L; Sbaiz L; Sedita AM; Banchieri N; Sapone L; Fiorucci GC; Brinson E; Shulse E; Rappaport E; Fortina P
J Med Screen; 1999; 6(2):67-9. PubMed ID: 10444722
[TBL] [Abstract][Full Text] [Related]
54. Genotyping microarray for the detection of more than 200 CFTR mutations in ethnically diverse populations.
Schrijver I; Oitmaa E; Metspalu A; Gardner P
J Mol Diagn; 2005 Aug; 7(3):375-87. PubMed ID: 16049310
[TBL] [Abstract][Full Text] [Related]
55. Targeted extended cystic fibrosis mutation testing on known and at-risk patients and relatives.
Lebo RV; Omlor GJ
Genet Test; 2007; 11(4):427-44. PubMed ID: 18294061
[TBL] [Abstract][Full Text] [Related]
56. Original research: parents and children with cystic fibrosis.
Lomas PH; Fowler SB
Am J Nurs; 2010 Aug; 110(8):30-7; quiz 38-9. PubMed ID: 20671493
[TBL] [Abstract][Full Text] [Related]
57. [Towards an improved antenatal screening for cystic fibrosis].
Serre JL; Feingold J; Simon-Bouy B; Muller F
Rev Epidemiol Sante Publique; 2003 Apr; 51(2):245-53. PubMed ID: 12876510
[TBL] [Abstract][Full Text] [Related]
58. Cystic Fibrosis: A Review of Associated Phenotypes, Use of Molecular Diagnostic Approaches, Genetic Characteristics, Progress, and Dilemmas.
Brennan ML; Schrijver I
J Mol Diagn; 2016 Jan; 18(1):3-14. PubMed ID: 26631874
[TBL] [Abstract][Full Text] [Related]
59. New possibilities for population control of cystic fibrosis.
Dodge JA; Boulyjenkov V
Bull World Health Organ; 1992; 70(5):561-6. PubMed ID: 1464143
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of genetic counseling among cystic fibrosis carriers, Michigan Newborn Screening.
Kleyn MJ; Langbo C; Abdulhamid I; Adamski CR; Allan C; Carmany EP; Gregoire-Bottex MM; Homnick D; Schuen J; Nasr SZ
Pediatr Pulmonol; 2013 Feb; 48(2):123-9. PubMed ID: 23169573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
